Clive Stubbs

2.3k total citations · 1 hit paper
17 papers, 558 citations indexed

About

Clive Stubbs is a scholar working on Obstetrics and Gynecology, Pediatrics, Perinatology and Child Health and Surgery. According to data from OpenAlex, Clive Stubbs has authored 17 papers receiving a total of 558 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Obstetrics and Gynecology, 5 papers in Pediatrics, Perinatology and Child Health and 4 papers in Surgery. Recurrent topics in Clive Stubbs's work include Maternal and Perinatal Health Interventions (5 papers), Pregnancy and preeclampsia studies (3 papers) and Maternal and fetal healthcare (3 papers). Clive Stubbs is often cited by papers focused on Maternal and Perinatal Health Interventions (5 papers), Pregnancy and preeclampsia studies (3 papers) and Maternal and fetal healthcare (3 papers). Clive Stubbs collaborates with scholars based in United Kingdom, Canada and Australia. Clive Stubbs's co-authors include John Primrose, Richard Fox, Lucy Wall, Deborah Stocken, T.R. Jeffry Evans, David Cunningham, Daniel H. Palmer, Paul J. Ross, Tim Meyer and Anthony Watkinson and has published in prestigious journals such as Journal of Clinical Oncology, BMJ and PLoS Medicine.

In The Last Decade

Clive Stubbs

15 papers receiving 551 citations

Hit Papers

Sorafenib in combination with transarterial chemoembolisa... 2017 2026 2020 2023 2017 100 200 300
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Sorafenib in combination with transarterial chemoembolisation in patients with unresectable hepatocellular carcinoma (TACE 2): a randomised placebo-controlled, double-blind, phase 3 trial
    2017 331 citations Tim Meyer, Richard Fox et al. ˜The œLancet. Gastroenterology & hepatology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Clive Stubbs United Kingdom 8 319 208 173 165 146 17 558
Yangxun Pan China 15 243 0.8× 149 0.7× 161 0.9× 108 0.7× 46 0.3× 55 492
Yizhen Fu China 13 227 0.7× 100 0.5× 112 0.6× 78 0.5× 72 0.5× 38 384
Shigenori Nagakura Japan 13 203 0.6× 429 2.1× 338 2.0× 279 1.7× 35 0.2× 22 597
Toshiro Kamoshida Japan 10 62 0.2× 295 1.4× 84 0.5× 254 1.5× 160 1.1× 47 509
Tian-Fu Wen China 8 172 0.5× 57 0.3× 204 1.2× 36 0.2× 46 0.3× 16 361
Carole Macaron United States 10 106 0.3× 107 0.5× 153 0.9× 107 0.6× 86 0.6× 40 334
France Gay Belgium 10 314 1.0× 205 1.0× 136 0.8× 142 0.9× 67 0.5× 12 552
Hiromitsu Ito Japan 7 357 1.1× 272 1.3× 294 1.7× 149 0.9× 24 0.2× 13 569
Ryusuke Yamaguchi Japan 4 339 1.1× 234 1.1× 126 0.7× 127 0.8× 48 0.3× 5 504

Countries citing papers authored by Clive Stubbs

Since Specialization
Citations

This map shows the geographic impact of Clive Stubbs's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Clive Stubbs with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Clive Stubbs more than expected).

Fields of papers citing papers by Clive Stubbs

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Clive Stubbs. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Clive Stubbs. The network helps show where Clive Stubbs may publish in the future.

Co-authorship network of co-authors of Clive Stubbs

This figure shows the co-authorship network connecting the top 25 collaborators of Clive Stubbs. A scholar is included among the top collaborators of Clive Stubbs based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Clive Stubbs. Clive Stubbs is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Moakes, Catherine A, Sergio A. Silverio, Gillian Horgan, et al.. (2025). Women's Childbirth Experiences in the WILL Randomised Trial (When to Induce Labour to Limit Risk in Pregnancy Hypertension): A Mixed Methods Analysis. BJOG An International Journal of Obstetrics & Gynaecology. 132(10). 1426–1437. 1 indexed citations
2.
Magee, Laura A., Jennifer A. Hutcheon, Jon Dorling, et al.. (2024). WILL (When to Induce Labour to Limit risk in pregnancy hypertension): A multicentre randomised trial. Pregnancy Hypertension. 36. 7–7.
3.
Magee, Laura A., Catherine A Moakes, Jon Dorling, et al.. (2024). Determining optimal timing of birth for women with chronic or gestational hypertension at term: The WILL (When to Induce Labour to Limit risk in pregnancy hypertension) randomised trial. PLoS Medicine. 21(11). e1004481–e1004481. 4 indexed citations
4.
Morton, Victoria Hodgetts, Catherine A Moakes, Jane Daniels, et al.. (2024). Cerclage suture type to prevent pregnancy loss in women requiring a vaginal cervical cerclage: the C-STICH RCT. Health Technology Assessment. 28(40). 1–44. 1 indexed citations
5.
6.
Hutcheon, Jennifer A., Jon Dorling, Catherine A Moakes, et al.. (2023). WILL (When to induce labour to limit risk in pregnancy hypertension): Protocol for a multicentre randomised trial. Pregnancy Hypertension. 32. 35–42. 2 indexed citations
7.
8.
Whitaker, Lucy, Lee Middleton, Jane Daniels, et al.. (2023). Ulipristal acetate versus levonorgestrel-releasing intrauterine system for heavy menstrual bleeding (UCON): a randomised controlled phase III trial. EClinicalMedicine. 60. 101995–101995. 9 indexed citations
9.
Zarkar, Anjali, Sarah Pirrie, Clive Stubbs, et al.. (2022). A Study of Pazopanib Safety and Efficacy in Patients With Advanced Clear Cell Renal Cell Carcinoma and ECOG Performance Status 2 (Pazo2): An Open label, Multicentre, Single Arm, Phase II Trial. Clinical Genitourinary Cancer. 20(5). 473–481. 2 indexed citations
10.
Gupta, Janesh, et al.. (2022). A randomized trial of synthetic osmotic cervical dilator for induction of labor vs dinoprostone vaginal insert. American Journal of Obstetrics & Gynecology MFM. 4(4). 100628–100628. 16 indexed citations
11.
Fox, Richard, et al.. (2018). Impact of sex on toxicity and outcome in the BILCAP study.. Journal of Clinical Oncology. 36(15_suppl). e16151–e16151. 1 indexed citations
12.
Stubbs, Clive, et al.. (2017). A Study of Angiogenesis Markers in Patients with Renal Cell Carcinoma Undergoing Therapy with Sunitinib. Anticancer Research. 37(1). 253–260. 11 indexed citations
13.
Meyer, Tim, Richard Fox, Yuk Ting, et al.. (2017). Sorafenib in combination with transarterial chemoembolisation in patients with unresectable hepatocellular carcinoma (TACE 2): a randomised placebo-controlled, double-blind, phase 3 trial. ˜The œLancet. Gastroenterology & hepatology. 2(8). 565–575. 331 indexed citations breakdown →
14.
Hall, Emma, Syed A. Hussain, Núria Porta, et al.. (2017). BC2001 long-term outcomes: A phase III randomized trial of chemoradiotherapy versus radiotherapy (RT) alone and standard RT versus reduced high-dose volume RT in muscle-invasive bladder cancer.. Journal of Clinical Oncology. 35(6_suppl). 280–280. 13 indexed citations
15.
Primrose, John, Richard Fox, Daniel H. Palmer, et al.. (2017). Adjuvant capecitabine for biliary tract cancer: The BILCAP randomized study.. Journal of Clinical Oncology. 35(15_suppl). 4006–4006. 134 indexed citations
16.
17.
Bridgewater, John, Clive Stubbs, & John Primrose. (2011). BILCAP: A randomized clinical trial evaluating adjuvant chemotherapy with capecitabine compared to expectant treatment alone following curative surgery for biliary tract cancer.. Journal of Clinical Oncology. 29(15_suppl). 4125–4125. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Yangxun Pan Breakdown of academic impact, for papers by Yizhen Fu Breakdown of academic impact, for papers by Shigenori Nagakura Breakdown of academic impact, for papers by Toshiro Kamoshida Breakdown of academic impact, for papers by Tian-Fu Wen Breakdown of academic impact, for papers by Carole Macaron Breakdown of academic impact, for papers by France Gay Breakdown of academic impact, for papers by Hiromitsu Ito Breakdown of academic impact, for papers by Ryusuke Yamaguchi
Rankless by CCL
2026